fluorometholone and olopatadine hydrochloride

fluorometholone has been researched along with olopatadine hydrochloride in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akman, A; Akova, YA; Borazan, M; Erbek, SS; Karalezli, A; Kiyici, H1
Agarwal, T; Chawla, B; Khurana, S; Sharma, N; Tandon, R; Titiyal, JS; Velpandian, T1
Celik, T; Turkoglu, EB1

Trials

3 trial(s) available for fluorometholone and olopatadine hydrochloride

ArticleYear
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Acta ophthalmologica, 2009, Volume: 87, Issue:5

    Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Child; Conjunctival Diseases; Conjunctivitis, Allergic; Dibenzazepines; Dibenzoxepins; Double-Blind Method; Edema; Eyelid Diseases; Female; Fluorometholone; Histamine H1 Antagonists; Humans; Imidazoles; Ketotifen; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Prospective Studies; Pruritus; Seasons; Tears; Treatment Outcome; Young Adult

2009
Comparison of olopatadine and fluorometholone in contact lens-induced papillary conjunctivitis.
    Eye & contact lens, 2010, Volume: 36, Issue:4

    Topics: Anti-Allergic Agents; Conjunctiva; Conjunctivitis, Allergic; Contact Lenses; Diagnosis, Differential; Dibenzoxepins; Double-Blind Method; Drug Therapy, Combination; Female; Fluorometholone; Follow-Up Studies; Humans; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Severity of Illness Index; Treatment Outcome; Young Adult

2010
Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.
    Current eye research, 2014, Volume: 39, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Dibenzoxepins; Drug Combinations; Female; Fluorometholone; Histamine H1 Antagonists, Non-Sedating; Humans; Ketorolac; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Placebos; Seasons; Treatment Outcome; Young Adult

2014